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Objectives The purpose of this study was to evaluate the role of the myocardial redox state in the development of in-
hospital complications after cardiac surgery and the effect of statins on the myocardial redox state.
Background Statins improve clinical outcome after cardiac surgery, but it is unclear whether they exert their effects by modi-
fying the myocardial redox state.
Methods We quantified myocardial superoxide anion (O2) and peroxynitrite (ONOO) and their enzymatic sources in
samples of the right atrial appendage (RAA) from 303 patients undergoing cardiac surgery who were followed
up until discharge, and in 42 patients who were randomized to receive 3-day treatment with atorvastatin 40
mg/d or placebo before surgery. The mechanisms by which atorvastatin modifies myocardial redox state were
investigated in 26 RAA samples that were exposed to atorvastatin ex vivo.
Results Atrial O2 (derived mainly from nicotinamide adenine dinucleotide phosphate [NADPH] oxidases) and ONOO
were independently associated with increased risk of atrial fibrillation, the need for post-operative inotropic sup-
port, and the length of hospital stay. Pre-operative atorvastatin treatment suppressed atrial NADPH oxidase ac-
tivity and myocardial O2
 and ONOO production. Ex vivo incubation of RAA samples with atorvastatin induced a
mevalonate-reversible and Rac1-mediated inhibition of NADPH oxidase.
Conclusions There is a strong independent association between myocardial O2/ONOO and in-hospital complications after
cardiac surgery. Both myocardial O2
 and ONOO are reduced by pre-operative statin treatment, through a
Rac1-mediated suppression of NADPH oxidase activity. These findings suggest that inhibition of myocardial
NADPH oxidases may contribute to the beneficial effect of statins in patients undergoing cardiac surgery. (Effects of
Atorvastatin on Endothelial Function, Vascular and Myocardial Redox State in High Cardiovascular Risk Patients;
NCT01013103) (J Am Coll Cardiol 2012;59:60–70) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.062Cardiac surgery is associated with a high risk of post-
operative complications such as atrial fibrillation (AF)—in
30% of patients—heart failure, and stroke (1) that pro-
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December 27, 2011/January 3, 2012:60–70 Myocardial Redox State and Cardiac Surgerylong hospitalization and have a major impact on the clinical
outcome of these patients (1,2). Increased atrial nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase activity
and altered myocardial redox state have been proposed as
possible mechanisms involved in the development and main-
tenance of AF (3–5). Although myocardial superoxide (O2
)
as been found to be higher in patients who have post-
perative AF (4), it is unclear whether other pro-oxidant
olecules such as peroxynitrite (ONOO), produced by the
eaction of O2
 with myocardial nitric oxide, may play any
additional role. Moreover, the impact of myocardial redox state
on other post-operative complications is unknown.
Recent evidence suggests that perioperative treatment
with statins reduces the risk of AF after cardiac surgery and
improves the post-operative outcome of these patients (6,7).
We have recently shown that pre-operative treatment with
statins reduces vascular oxidative stress by decreasing the
activity of NADPH oxidase in human vein grafts (8). Statins
reduce myocardial oxidative stress in experimental animal
models (9) and prevent atrial electrical remodeling leading
to AF (10). However, clinical data implying an effect of
statins on myocardial redox state in humans are scanty
and limited to a small observational study (11).
In the present study, we examined the role of atrial O2
 and
NOO in the prediction of post-operative complications
fter cardiac surgery, and evaluated the contribution of indi-
idual sources of O2
 in the development of these complica-
tions. We then explored the hypothesis that pre-operative
treatment with statins has a beneficial effect on myocardial
redox state in these patients and investigated the molecular
mechanisms underlying this effect.
Methods
Study population and design. The studies were approved
by the institutional ethics committee, and all subjects gave
written informed consent.
Prospective study. The study population consisted of 303
patients undergoing cardiac surgery (Table 1). Patients were
recruited pre-operatively, and exclusion criteria were any
inflammatory, infective, liver, renal disease, or malignancy.
Patients receiving nonsteroidal anti-inflammatory drugs,
dietary supplements (such as folates), or antioxidant vita-
mins were excluded. Patients in sinus rhythm (SR) who
were taking any antiarrhythmic medication, other than
beta-blockers, were also excluded.
Blood samples were obtained the morning before surgery
after 8 h of fasting, whereas samples of right atrial appendages
(RAA) were obtained at the time of cardiopulmonary bypass
and stored at 80oC until assayed. All subjects were followed
up prospectively until their discharge from the hospital.
Surface electrocardiography was continuously monitored
for the first 48 h after surgery in the intensive care unit. After
the patients were transferred to the cardiothoracic ward, heart
rhythm was evaluated every 4 h by electrocardiography and
whenever a relevant sign or symptom was reported, until their odischarge from the hospital. Any
episode of AF lasting 30 s was
classified as post-operative AF
(4,12). Additional clinical data
were collected, including length of
hospital stay, the need for inotro-
pic support, and the appearance of
major cardiovascular events (such
as need for redo surgery, acute
heart failure, or death) during their
hospital stay.
Effects of pre-operative treat-
ment with atorvastatin on myo-
cardial redox state. Forty-two
statin-naïve patients undergoing
elective coronary artery bypass
graft surgery (CABG) were as-
signed randomly (using block
randomization) to receive either
atorvastatin 40 mg/day or placebo
tablet of similar size, shape, and
color for 3 days pre-operatively, in
a double-blind fashion. Serum
lipid levels were measured at base-
line and on the morning before
surgery, and the results were made
available to the researchers at the
end of the study. At the time of
surgery, a sample of the RAA was obtained. In addition to the
exclusion criteria listed, patients were excluded if they had
known intolerance to statins or had received statin treatment
during the last 3 months.
Ex vivo effects of atorvastatin on myocardial sources of
reactive oxygen species production. For the ex vivo ex-
periments, RAA samples from 26 patients in SR undergo-
ing CABG were obtained. Exclusion criteria were as de-
scribed above. Using a pre-cooled Polytron homogenizer
(PT2100 Kinematika, Lucerne, Switzerland), 40 to 70 mg
snap-frozen RAA tissue (stored at 80°C) was homoge-
nized for 30 s in 800 l ice-cold Krebs-Hepes buffer
containing a protease inhibitor cocktail (Roche Applied
Science, Indianapolis, Indiana). Atrial homogenates were
then spun at 13,000 rpm at 4°C, after which the supernatant
was used for the experiment. Each sample was split into 3
aliquots, and incubated for 60 min at 37°C in a water bath in
the presence of atorvastatin 20 mol/l, atorvastatin 20 mol/l
plus mevalonate 200 mol/l, or buffer alone (control). Then
he samples were frozen at 80°C until luminometry experi-
ents were performed (see the following text). The Rac1
ctivity, defined by the guanosine triphosphate-Rac1 to total
ac1 ratio, was evaluated by a commercially available affinity
recipitation assay (Millipore, Temecula, California).
easurement of myocardial O2
/ONOO. The O2
 pro-
uction was measured in homogenized RAA tissue by
ucigenin-enhanced chemiluminescence, as described previ-
Abbreviations
and Acronyms
AF  atrial fibrillation
ANOVA  analysis of
variance
CABG  coronary artery
bypass graft surgery
CI  confidence interval
EuroSCORE  European
System for Cardiac
Operative Risk Evaluation
HR  hazard ratio
LDL  low-density
lipoprotein
LVEF  left ventricular
ejection fraction
MDA  malonyldialdehyde
NADPH  nicotinamide
adenine dinucleotide
phosphate
O2
  superoxide anion
ONOO  peroxynitrite
RAA  right atrial
appendage
RLU  relative light units
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oxidase activity. The NADPH oxidase inhibitor apocynin (1
mmol/l) was then added, and the apocynin-inhibitable fraction
was determined. The contribution of mitochondrial oxidases to
the overall O2
 signal was evaluated by the signal inhibitable
by rotenone (100 mol/l).
To determine myocardial ONOO production, we eval-
uated the luminol (100 mmol/l) chemiluminescence inhib-
itable by urate (1 mmol/l), as described previously (13).
Measurements of plasma malonyldialdehyde levels.
Plasma malonyldialdehyde (MDA) levels (a marker of
systemic lipid peroxidation) were measured by using a
fluorometric technique previously described (8,14).
Measurements of serum lipid levels. Serum lipid levels
were measured by using a chromatographic enzymatic
method in the Technicon automatic analyzer RA-1000
(Dade-Behring, Deerfield, Illinois). These results became
available to the researchers at the end of the study, to
Patient Demographics and Clinical CharacteristTable 1 Patient Demographics and Clinical
Study 1 (Prospective)
Participants 303
Male/female 248/55
Age, yrs 66.74 9.1
CABG/AVR 284/19
Hypertension 208 (69)
Diabetes mellitus 87 (29)
Dyslipidemia 171 (56)
Smoking
Active smokers 76 (25)
Ex-smokers 132 (44)
BMI, kg/m2 27.6 4.4
Urea, mg/dl 44.4 20.3
Creatinine, mg/dl 1.07 0.29
Cholesterol, mg/dl 181 42
LDL, mg/dl 115 39
HDL, mg/dl 38.6 9.6
TG, mg/dl 123 [94–156]
EuroSCORE 4.31 2.8
Chronic AF 22 (7.3)
LVEF, % 50.4 11.9
LA diameter, mm 40.7 9.2†
Time on bypass, min 101.9 69.3
Medications,
Aspirin or clopidogrel 225 (75)
Statin 212 (70)
Beta-blocker 185 (61)
CCB 63 (21)
ACEi or ARB 190 (63)
Diuretics 112 (37)
Values are n, mean SD, n (%), or median [25th to 75th percentile]. *N
ACEi  angiotensin-converting enzyme inhibitor; ARB  angiotensin
CABG  coronary artery bypass graft surgery; CCB  calcium-cha
Evaluation; HDL  high-density lipoprotein; LA  left atrium; LDL
triglycerides.maintain its blinded design. AStatistical analysis. All continuous variables were tested
for normal distribution by visual inspection of the data and
by using the Kolmokorov-Smirnov test. Normally distrib-
uted variables are expressed as mean SD (unless otherwise
ndicated) whereas nonnormally distributed variables are
iven as median [25th to 75th percentile].
Comparisons of normally distributed variables between
roups were performed by using unpaired t tests or 1-way
nalysis of variance (ANOVA) for multiple comparisons
ollowed by Bonferroni post-hoc correction, as appropriate.
omparisons of non-normally distributed variables between
roups were performed by using the Mann-Whitney U test
r the Kruskal-Wallis 1-way ANOVA as appropriate.
hen the Kruskal-Wallis test was significant, then the
ann-Whitney U test was used for individual comparisons,
ollowed by Bonferroni post-hoc correction.
For comparison of the effect of treatment on variables (e.g.,
or changes of lipid levels in the randomized study), 2-way
cteristics
Study 2 (Oral Atorvastatin)
Study 3 Ex Vivo
Atorvastatinlacebo Atorvastatin
21 21 26
20/1 18/3* 23/3
8 9.1 66.1 9.3* 69.5 8.1
21/0 21/0* 26/0
6 (76) 18 (90)* 17 (65)
9 (43) 7 (33)* 6 (23)
— — 20 (77)
7 (33) 8 (38)† 6 (23)
0 (48) 9 (43)† 14 (54)
.7 3.6 27.5 3.3† 26.0 5.0
.7 10.6 41.7 15.1† 50.69 22.4
6 0.16 1.02 0.19* 1.11 0.37
7 43 184 47* 169 26
9 32 113 34* 103 23
.8 8.0 38.7 9.5* 35.9 6.4
[90–284] 157 [106–271]* 122 [98–149]
9 2.9 3.56 2.9* 4.53 2.1
3 (14) 3 (14)* 
.0 10.4 50.1 14.6* 58.8 4.1
.0 8.9 39.2 9.0*† 41.6 6.9
.5 49.9 116.3 37.1*† 98.0 36.9
6 (80) 17 (81)* 20 (77)
— — 18 (69)
3 (62) 13 (62)* 12 (46)
5 (24) 5 (24)* 5 (19)
2 (57) 17 (80)* 17 (65)
8 (39) 10 (47)* 11 (42)
ificant versus placebo. †Measurement available for only 226 patients.
or blocker; AVR  aortic valve replacement; BMI  body mass index;
ocker; EuroSCORE  European System for Cardiac Operative Risk
density lipoprotein; LVEF  left ventricular ejection fraction; TG icsChara
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December 27, 2011/January 3, 2012:60–70 Myocardial Redox State and Cardiac Surgeryinteraction was used. In the ex vivo experiments (where tissue
aliquots from the same patient were exposed to 3 interven-
tions), when a significant p value was obtained using 1-way
ANOVA for repeated measures, the effect of treatment was
examined by paired t tests, using the actual (if normally
distributed) or log-transformed values (if non-normally distrib-
uted), followed by Bonferoni post-hoc correction. Dichoto-
mous variables were compared between groups by using the
chi-square test.
Power calculations for study 1 showed that with 280 patients
in SR undergoing CABG, we would be able to detect a true
hazard ratio 1.87 for post-operative AF between the 2 extreme
tertiles of NADPH-stimulated O2
, with power 0.9 and  
.05. For study 2, we estimated that 42 patients would allow us
o detect a 10% difference of the log (NADPH-stimulated
2
) between the 2 groups, with power 90% and   0.05.
For study 3, we estimated that by using 3 paired samples we
would be able to detect a 30% difference of Rac1 activation
between control and treated samples, with power 90% and 
0.05. Pearson’s r or Spearman’s rho simple correlation coeffi-
cients were estimated, as appropriate.
To evaluate the association between measures of myocar-
dial redox state (basal O2
, NADPH-stimulated O2
,
pocynin-inhibitable O2
, rotenone-inhibitable O2
, and
ONOO) and post-operative outcome (i.e., AF and length
f hospitalization), the study population was divided into
ertiles of the redox measurements, and comparisons be-
ween Kaplan-Meier curves, defined by these tertiles (as
ell as by using the continuous variables), were performed
y using Cox regression. In these models, redox measure-
ents (as tertiles) and variables (e.g., age, sex, hypertension,
iabetes mellitus, dyslipidemia, smoking, body mass index,
uroSCORE [European System for Cardiac Operative
isk Evaluation], left ventricular ejection fraction (LVEF),
re-existing AF, or medication such as beta-blockers and
tatins) that showed an association (p  0.10 by using
ppropriate univariate Cox models) with post-operative
omplications were used as covariates.
To evaluate the association of myocardial redox state with
he duration of inotropic support, we performed multiple
inear regression, in which the actual duration of inotropic
upport (in days) was used as dependent (continuous) variable;
hereas as independent variables, we used measures of myo-
ardial redox state (as stated) as well as the patients’ character-
stics (age, sex, hypertension, diabetes, hypercholesterolemia,
moking, body mass index, medication, and EuroSCORE)
hat showed a relevant simple association with the dependent
ariable at the level of p  0.10.
All statistical analyses were performed by using SPSS
ersion 18.0 (SPSS, Chicago, Illinois), and p values were
onsidered significant if  0.05.
esults
he demographic and clinical characteristics of the partic-
pants are presented in Table 1. The patients in the 1rospective study were hospitalized for a median of 8 days
range 5 to 28 days). During follow-up, 3 patients died, 203
atients required post-operative inotropic support (138 for 1
ay, 38 for 2 days, and 27 for 3 or more days), and 80 had
ost-operative AF; no redo operations were required.
ost-operative atrial fibrillation. To identify the clinical
nd biochemical parameters associated with the new onset
f AF in the post-operative period in patients in SR (n 
81), we first screened the potential covariates by using
nivariate Cox regression. We found that the risk of
ost-operative AF was increased with age (hazard ratio
HR]: 1.051, 95% confidence interval [CI]: 1.024 to 1.079,
 0.0001) and EuroSCORE (HR: 1.094, 95% CI: 1.056
o 1.134, p  0.0001) and reduced by the use of beta-
lockers (HR: 0.469, 95% CI: 0.299 to 0.733). Left atrial
ize was also correlated with the development of post-
perative AF (HR: 1.055, 95% CI: 1.018 to 1.094, p 
.004), but this variable was not included in the multivari-
ble Cox-regression model as it was available for only 209
atients. There was no significant association between prior
tatin use and post-operative AF among these patients (HR:
.213, 95% CI: 0.756 to 1.947, p  0.423); however, most
f the patients who were in SR before surgery were receiving
reatment with statins (73%). Aortic valve replacement
urgery and LVEF were not associated with post-operative
F and were not included in any analysis.
Pre-operative plasma MDA was similar between patients
ho had post-operative AF (median [25th to 75th percen-
ile]: 1.10 [0.85 to 1.47] mol/l) and patients who remained
in SR (1.09 [0.80 to 1.46] mol/l, p  NS). However,
patients who had post-operative AF had significantly higher
basal myocardial O2
 (84 [59 to 146] vs. 68.3 [48 to 86]
relative light units per second per milligram [RLU/s/mg],
p  0.003), NADPH-stimulated O2
 (31,142 [14,850 to
47,430] RLU/s/mg vs. 14,410 [6,329 to 27,937] RLU/s/
mg, p  0.0001) and ONOO production (239 [113 to
484] RLU/s/mg protein vs. 152 [79 to 229] RLU/s/mg
protein, p  0.003). Similarly, the apocynin-inhibitable
O2
 fraction of NADPH-stimulated O2
 was greater in
atients who had postoperative AF (6,655 [4,024 to 13,475]
LU/s/mg protein vs. 3,609 [1,644 to 7,583] RLU/s/mg
rotein, p  0.0001). By contrast, no difference in myocar-
ial rotenone-inhibitable O2
 was observed between groups
(3.1 [7.6 to 25.4] RLU/s/mg protein in patients who had
AF vs. 7.4 [0 to 14.8] RLU/s/mg protein in patients who
maintained SR after surgery, p  NS).
To investigate the contribution of myocardial redox state
to post-operative AF, we plotted the Kaplan-Meier curves
for the development of AF by using tertiles of each of these
measures and performed Cox regression to compare the
tertiles after adjustment for relevant clinical variables.
Plasma MDA showed no association with the development
of post-operative AF (Fig. 1A); however, basal and
NADPH-stimulated O2
 (Figs. 1B and 1C), and the
pocynin-inhibitable fraction of O2
 (HR: 4.68, 95% CI:
.32 to 16.66, p  0.017 for mid vs. lowest tertile; and HR:
s
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lowest tertile) were strongly associated with the develop-
ment of post-operative AF, even after adjusting for age, use
of beta-blockers, and EuroSCORE. Myocardial ONOO
was also associated with post-operative AF in these patients
(Fig. 1D).
Length of hospitalization. In the univariate Cox regres-
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Figure 1 Systemic Lipid Peroxidation and Redox State in Right
(A) Plasma malonyldialdehyde (MDA) was not associated with post-operative atria
phate (NADPH)-stimulated superoxide (O2
) production, as well as (D) peroxynitrit
ard ratio (HR [95% confidence interval (CI)]), p value derived from Cox regression,
used as a continuous variable in each analysis, the respective adjusted p values
stimulated O2
, and 0.001 for myocardial ONOO. Blue lines  lowest tertile; gre
tem for Cardiac Operative Risk Evaluation; pts  patients.sion, the length of hospital stay was associated with age(HR: 0.98, 95% CI: 0.97 to 0.99, p  0.005), female sex
(HR: 0.72, 95% CI: 0.54 to 0.98, p  0.036), hyperten-
ion (HR: 1.37, 95% CI: 1.06 to 1.77, p 0.016) and diabetes
HR: 0.73, 95% CI: 0.56 to 0.95, p 0.021), while there was
borderline association with the EuroSCORE (HR: 0.93,
5% CI: 0.88 to 1.02, p 0.09) and prior statin therapy (HR:
.24, 95% CI: 0.99 to 1.60, p  0.08); all these variables were
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length of hospitalization (HR: 1.05, 95% CI: 1.01 to 1.94, p
0.002) and was included in the respective multivariable Cox
regression analysis. Left atrial diameter was associated with the
length of hospital stay (HR: 0.97, 95% CI: 0.94 to 0.99, p 
0.002), but it was not included in the multivariable Cox
regression model because this measurement was only available
for 226 patients. Aortic valve replacement was not associated
with the length of hospital stay.
To investigate the possible contribution of systemic/
myocardial redox state to the length of hospitalization, we
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Figure 2 Systemic Lipid Peroxidation and Redox State in Right
The length of hospital stay was significantly associated with (A) plasma malonyldi
dinucleotide phosphate (NADPH)-stimulated O2
, while a borderline association wa
fidence interval (CI)]), p value derived from Cox regression after adjustment for age
ejection fraction. When redox state was used as a continuous variable in each an
myocardial O2
, p  0.008 for myocardial NADPH-stimulated O2
, and p  0.05
red lines  highest tertile. EuroSCORE  European System for Cardiac Operativefirst examined the associations between the latter and
individual measures of systemic or myocardial redox state.
The length of hospital stay was correlated with plasma
MDA (rho  0.231, p  0.001), basal O2
 (rho  0.184,
p  0.008), myocardial NADPH-stimulated O2
 (rho 
0.273, p  0.001), apocynin-inhibitable O2
 (rho  0.259,
 0.002), and ONOO (rho  0.180, p  0.034). There
as no association between the length of hospitalization and
otenone-inhibitable O2
 (rho  0.04, p  0.712).
Comparisons of the Kaplan-Meier curves between tertiles
f redox measurements by using Cox regression showed that
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Myocardial Redox State and Cardiac Surgery December 27, 2011/January 3, 2012:60–70pre-operative plasma MDA (Fig. 2A), basal myocardial O2

(Fig. 2B), NADPH-stimulated myocardial O2
 (Fig. 2C) and
ts apocynin-inhibitable fraction (HR: 0.593, 95% CI: 0.366 to
.962, p  0.034 for highest vs. lowest tertiles of apocynin-
inhibitable O2
), and ONOO (Fig. 2D) were associated
ith the length of hospitalization after adjustment for age, sex,
iabetes, hypertension, use of statins, LVEF, and Euro-
CORE. Statin treatment was not a significant predictor of
ength of hospital stay in any of the Cox-regression models
data not shown).
Importantly, when post-operative AF was included in the
ox-regression models, the association between the length
f hospital stay and systemic/myocardial redox state (such as
lasma MDA [HR: 0.67, 95% CI: 0.45 to 0.98, p  0.04
or mid vs. lowest tertiles and HR: 0.48, 95% CI: 0.31 to
.75, p  0.001 for highest vs. lowest tertiles of plasma
DA]), NADPH-stimulated myocardial O2
 generation
(HR: 0.67, 95% CI: 0.43 to 0.99, p  0.048 for the highest
vs. lowest tertile of NADPH-stimulated O2
), and
NOO (HR: 0.63, 95% CI: 0.41 to 0.97, p  0.04),
uggesting that systemic lipid peroxidation (as assessed by
DA), atrial NADPH oxidase activity, and ONOO may
predict the length of hospitalization, independent of their
effect on post-operative AF.
In the whole study population, plasma MDA was
weakly correlated with myocardial NADPH-stimulated
O2
 (rho  0.181, p  0.029) and basal myocardial O2

(rho  0.155, p  0.065). There was no association
etween plasma MDA and myocardial ONOO (rho 
0.034, p  0.701).
Post-operative inotropic support. Age (rho  0.191, p 
0.004), hypertension (rho  0.112, p  0.09), diabetes
(rho  0.115, p  0.08), EuroSCORE (rho  0.242, p 
0.001), pre-existing heart failure (rho 0.270, p 0.0001),
VEF (rho  0.207, p  0.002), chronic AF (rho 
Multivariate Predictive Models for Duration of PTable 2 Multivariate Predictive Models for D
Variables
Model 1: clinical characteristics
Age
Hypertension
Diabetes Mellitus
EuroSCORE
Pre-existing heart failure
Chronic atrial fibrillation
Time on bypass
Model 2: clinical characteristics  NADPH-stimulated O2

Age
Hypertension
Diabetes mellitus
EuroSCORE
Pre-existing heart failure
Chronic atrial fibrillation
Time on bypass
NADPH-stimulated O2
EuroSCORE European System for Cardiac Operative Risk Evaluation; NADPH0.271, p  0.0001), and the time on bypass (rho  0.143,
p 0.023) were all associated with the duration of inotropic
upport. In the multivariate analysis, the regression model
ased on these clinical variables was significantly strength-
ned when myocardial NADPH-stimulated O2
 was in-
cluded (Table 2).
When we classified the patients into 3 groups according
to the duration of post-operative inotropic support (i.e.,
those who required 0 days, 1 day, or 2 days of inotropic
support), we observed no association between the need for
inotropic support and either pre-operative plasma MDA
(Fig. 3A) or basal myocardial O2
 (Fig. 3B). In contrast,
he duration of inotropic support was increased in parallel
ith the increase of myocardial NADPH-stimulated O2

(Fig. 3C), and the apocynin-inhibitable O2
 (rho  0.250,
p  0.002). Similarly, myocardial ONOO increased in
arallel with the duration of inotropic support during the
ost-operative period (Fig. 3D).
ffects of short-term pre-operative atorvastatin treatment
n the myocardial redox state. The findings from our
rospective study underscore the importance of measures of
yocardial redox state as markers of clinical outcome after
ardiac surgery. Statin treatment has been associated with
mproved postoperative outcome (6,7); here, we explored
hether short-term pre-operative treatment with atorvasta-
in 40 mg/day affects the myocardial redox state. After 3
ays of treatment, there was a small reduction in serum
ow-density lipoprotein (LDL) cholesterol in the
torvastatin-treated group (by 13.9  28.3 mg/dl), which
was, however, not significantly different from the change
observed after placebo (by 4.2  24.1 mg/dl, p  0.290
or the interaction). Similarly, the changes of high-density
ipoprotein (by 3.05  7.1 mg/dl) and triglycerides (by
10.4  57.5 mg/dl) after atorvastatin treatment were not
ignificantly different compared to the changes after placebo
perative Inotropic Supportion of Post-Operative Inotropic Support
R2 for Model Coefficient (Adjusted , p Value)
0.218
0.072, 0.298
0.038, 0.559
0.115, 0.830
0.015, 0.830
0.116, 0.080
0.164, 0.021
0.355, 0.0001
0.317
0.080, 0.326
0.045, 0.542
0.063, 0.404
0.018, 0.817
0.097, 0.186
0.121, 0.170
0.398, 0.0001
0.208, 0.020ost-Ouratnicotinamide adenine dinucleotide phosphate; O2
 superoxide anion.
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p  0.374 and p  0.904 for the interaction, respectively).
owever, patients who received atorvastatin showed a
ignificantly lower basal O2
 and ONOO in the RAA
Figs. 4A and 4C), as well as a reduction in the NADPH-
timulated O2
 (Fig. 4B) and in the apocynin-inhibitable
O2
 (p  0.001; data not shown). Conversely, the
otenone-inhibitable O2
 was not affected by atorvastatin
(p  NS; data not shown). There was no association
between the change of LDL and basal O2
 (rho0.055,
 0.750), NADPH-stimulated O2
 (rho  0.096, p 
.594), apocynin-inhibitable O2
 (rho0.066, p 0.740),
rotenone-inhibitable O2
 (rho  0.015, p  0.950), or
ONOO (rho  0.088, p  0.638) in the RAA of these
patients. These findings support the notion that the effect of
atorvastatin on myocardial redox state is independent of LDL
lowering.
Effects of ex vivo atorvastatin on myocardial redox state.
To further explore the mechanisms by which statins affect the
myocardial redox state, we incubated RAA samples from 26
patients with atorvastatin 20 mol/l for 1 h. Atorvastatin
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Figure 3 Associations Between Systemic Lipid Peroxidation/M
the Need/Duration of Inotropic Support After Surgery
The duration of inotropic support in the post-operative period was independent of
nificant association with (C) atrial nicotinamide adenine dinucleotide phosphate (N
derived from Kruskal- Wallis 1-way analysis of variance. *p  0.05 and **p  0.0
expressed as median (25th to 75th percentile). Green bars  0 days; gold bars caused a mevalonate-reversible reduction of myocardial O2
 n(derived from NADPH oxidase) and ONOO (Figs. 5A and
B) and the guanosine triphosphate-Rac1 to total Rac1 ratio
Figs. 5C and 5D). Together, these findings suggest that
nhibition of 3-hydroxy-3-methylglutaryl-coenzyme A
HMG-CoA) reductase by statins effectively reduces myocar-
ial Rac1 and NADPH oxidase activity, independently of
DL lowering.
iscussion
n the present study, we demonstrate that myocardial RAA
2
 (derived mainly from NADPH oxidases) and ONOO
are independent predictors of post-operative complications
(i.e., AF and need for inotropic support) and the length of
hospital stay among patients undergoing cardiac surgery. We
also show that short-term pre-operative treatment with ator-
vastatin (40 mg/d) reduces myocardial O2
 and ONOO by
reducing NADPH oxidase activity, and that ex vivo incubation
of human RAA tissue with atorvastatin reduces NADPH
oxidase activity and myocardial O2
/ONOO production by
mevalonate-dependent inhibition of Rac1 activation. These
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Myocardial Redox State and Cardiac Surgery December 27, 2011/January 3, 2012:60–70ONOO production (mainly by NADPH oxidases) may
contribute to the beneficial effect of statins in patients under-
going cardiac surgery.
Myocardial redox state and prediction of post-operative
complications. Atrial fibrillation is the most common
complication after cardiac surgery (occurring in 30% of
patients), leading to hemodynamic instability and prolonged
hospitalization (1,2). Age and the use of beta-blockers (2) as
well as risk scores, such as the EuroSCORE (12), have been
consistently associated with the new onset of post-operative
AF after CABG surgery. Recent studies have suggested
that myocardial O2
 affects atrial electrical remodeling
(15,16) and is associated with an increased risk of
post-operative AF after cardiac surgery (4). However, the
role of other highly toxic reactive oxygen species such as
ONOO in the development of post-operative compli-
ations is unknown.
In the present study, we show that right atrial O2

production (mainly derived from NADPH oxidase) is an
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Figure 4 Effect of Short-Term Pre-Operative
Atorvastatin Treatment on Myocardial Redox State
Pre-operative 3-day treatment with atorvastatin (40 mg/d) reduced (A) myocar-
dial basal superoxide (O2
) as well as (B) nicotinamide adenine dinucleotide
phosphate (NADPH)-stimulated O2
, and (C) peroxynitrite (ONOO) compared
to placebo. Values are expressed as median (25th to 75th percentile). Red
bars  placebo; green bars  atorvastatin. RLU  relative light units.independent predictor of post-operative AF in patients under- cgoing cardiac surgery. We also show for the first time that
myocardial ONOOmay be involved into the pathogenesis of
post-operative AF. Myocardial O2
 and ONOO were also
associated with the need for post-operative inotropic support,
whereas both systemic lipid peroxidation and myocardial NA-
DPH oxidase activity were strong predictors of the length of
hospitalization, independent of post-operative AF. In contrast,
MDA was not associated with post-operative AF or with
measurements of myocardial redox state.
Myocardial redox state as a therapeutic target of statin
treatment. Recent studies have suggested that pre-
operative treatment with statins reduces the risk of post-
operative AF and improves the overall clinical outcome after
cardiac surgery (6,7). However, despite previous reports
indicating that statins reduce myocardial NADPH oxidase
activity in experimental animal models (17), the clinical data
are limited (11). In the present study, statin treatment prior
to surgery was associated with shorter hospital stay (but not
with post-operative AF); however, this association did not
hold when included in Cox regression analyses. It should be
noted that most of SR patients were receiving statins at the
time of surgery (73%), and 33% of them were taking
comparatively low doses. To explore the effect of high-dose
statin treatment on myocardial redox state, we performed a
randomized placebo-controlled study, in which treatment
with atorvastatin 40 mg/d for only 3 days before cardiac
surgery reduced myocardial ONOO and NADPH oxidase
activity. We also showed that ex vivo incubation of human
atrial homogenates with atorvastatin results in a mevalonate-
reversible reduction in NADPH oxidase activity (partly by
suppressing Rac1 activation) and myocardial O2
/ONOO
production, supporting the notion that the effects of statins
on myocardial redox are independent of LDL cholesterol
lowering. The rapidity of this effect (which was observed
after 1-h incubation with atorvastatin) suggests that
isoprenoids are rapidly depleted in in vitro tissue prepa-
rations. Indeed, in cell culture models, atorvastatin in-
duces significant biological changes (e.g., in intracellular
adenosine monophosphate protein kinase levels and en-
dothelial nitric oxide synthase phosphorylation status) as
early as after 10 min of incubation (18), whereas 6-h
incubation of human saphenous veins with atorvastatin
inhibits NADPH-oxidase, through suppression of Rac1-
activation (8).
Conclusions
Myocardial O2
 and ONOO are strong independent
redictors of in-hospital clinical outcome in patients under-
oing cardiac surgery, as atrial production of these oxidant
nd nitrating species is independently associated with the
evelopment of post-operative AF, the need for inotropic
upport, and the overall length of hospitalization. Our study
onfirms that NADPH oxidases are the main enzymatic
ource of atrial O2
 production in patients in SR undergoing
ardiac surgery, and it shows that short-term statin treatment
s
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 and ONOO generation mainly by
uppressing Rac1 and NADPH oxidase activity. These effects
re due to the direct, rapid inhibition of HMG-CoA reductase
n the human atrial tissue and are independent of LDL
holesterol lowering. Together, these novel findings suggest
hat suppressing O2
 formation from myocardial NADPH
oxidases may improve in-hospital outcome for patients under-
going cardiac surgery.
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